297 related articles for article (PubMed ID: 24509440)
1. The role of vascular-derived perlecan in modulating cell adhesion, proliferation and growth factor signaling.
Lord MS; Chuang CY; Melrose J; Davies MJ; Iozzo RV; Whitelock JM
Matrix Biol; 2014 Apr; 35():112-22. PubMed ID: 24509440
[TBL] [Abstract][Full Text] [Related]
2. Perlecan inhibits smooth muscle cell adhesion to fibronectin: role of heparan sulfate.
Lundmark K; Tran PK; Kinsella MG; Clowes AW; Wight TN; Hedin U
J Cell Physiol; 2001 Jul; 188(1):67-74. PubMed ID: 11382923
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of abdominal aortic aneurysms: possible role of differential production of proteoglycans by smooth muscle cells.
Melrose J; Whitelock J; Xu Q; Ghosh P
J Vasc Surg; 1998 Oct; 28(4):676-86. PubMed ID: 9786264
[TBL] [Abstract][Full Text] [Related]
4. Heparan and chondroitin sulfate on growth plate perlecan mediate binding and delivery of FGF-2 to FGF receptors.
Smith SM; West LA; Govindraj P; Zhang X; Ornitz DM; Hassell JR
Matrix Biol; 2007 Apr; 26(3):175-84. PubMed ID: 17169545
[TBL] [Abstract][Full Text] [Related]
5. Perlecan heparan sulfate deficiency impairs pulmonary vascular development and attenuates hypoxic pulmonary hypertension.
Chang YT; Tseng CN; Tannenberg P; Eriksson L; Yuan K; de Jesus Perez VA; Lundberg J; Lengquist M; Botusan IR; Catrina SB; Tran PK; Hedin U; Tran-Lundmark K
Cardiovasc Res; 2015 Jul; 107(1):20-31. PubMed ID: 25952902
[TBL] [Abstract][Full Text] [Related]
6. Heparan sulfate side chains have a critical role in the inhibitory effects of perlecan on vascular smooth muscle cell response to arterial injury.
Gotha L; Lim SY; Osherov AB; Wolff R; Qiang B; Erlich I; Nili N; Pillarisetti S; Chang YT; Tran PK; Tryggvason K; Hedin U; Tran-Lundmark K; Advani SL; Gilbert RE; Strauss BH
Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H337-45. PubMed ID: 24858854
[TBL] [Abstract][Full Text] [Related]
7. Lead inhibits the core protein synthesis of a large heparan sulfate proteoglycan perlecan by proliferating vascular endothelial cells in culture.
Fujiwara Y; Kaji T
Toxicology; 1999 Apr; 133(2-3):159-69. PubMed ID: 10378482
[TBL] [Abstract][Full Text] [Related]
8. Human perlecan immunopurified from different endothelial cell sources has different adhesive properties for vascular cells.
Whitelock JM; Graham LD; Melrose J; Murdoch AD; Iozzo RV; Underwood PA
Matrix Biol; 1999 Apr; 18(2):163-78. PubMed ID: 10372557
[TBL] [Abstract][Full Text] [Related]
9. Removal of heparan sulfate by heparinase treatment inhibits FGF-2-dependent smooth muscle cell proliferation in injured rat carotid arteries.
Kinsella MG; Irvin C; Reidy MA; Wight TN
Atherosclerosis; 2004 Jul; 175(1):51-7. PubMed ID: 15186946
[TBL] [Abstract][Full Text] [Related]
10. Myeloperoxidase-derived oxidants selectively disrupt the protein core of the heparan sulfate proteoglycan perlecan.
Rees MD; Whitelock JM; Malle E; Chuang CY; Iozzo RV; Nilasaroya A; Davies MJ
Matrix Biol; 2010 Jan; 29(1):63-73. PubMed ID: 19788922
[TBL] [Abstract][Full Text] [Related]
11. Peroxynitrite modifies the structure and function of the extracellular matrix proteoglycan perlecan by reaction with both the protein core and the heparan sulfate chains.
Kennett EC; Rees MD; Malle E; Hammer A; Whitelock JM; Davies MJ
Free Radic Biol Med; 2010 Jul; 49(2):282-93. PubMed ID: 20416372
[TBL] [Abstract][Full Text] [Related]
12. Platelet Factor 4 Binds to Vascular Proteoglycans and Controls Both Growth Factor Activities and Platelet Activation.
Lord MS; Cheng B; Farrugia BL; McCarthy S; Whitelock JM
J Biol Chem; 2017 Mar; 292(10):4054-4063. PubMed ID: 28115521
[TBL] [Abstract][Full Text] [Related]
13. Induction of synthesis of a large heparan sulfate proteoglycan, perlecan, by thrombin in cultured human coronary smooth muscle cells.
Yamamoto C; Wakata T; Fujiwara Y; Kaji T
Biochim Biophys Acta; 2005 Feb; 1722(1):92-102. PubMed ID: 15716125
[TBL] [Abstract][Full Text] [Related]
14. Heparan sulfate-dependent signaling of fibroblast growth factor 18 by chondrocyte-derived perlecan.
Chuang CY; Lord MS; Melrose J; Rees MD; Knox SM; Freeman C; Iozzo RV; Whitelock JM
Biochemistry; 2010 Jul; 49(26):5524-32. PubMed ID: 20507176
[TBL] [Abstract][Full Text] [Related]
15. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease.
Snow AD; Kinsella MG; Parks E; Sekiguchi RT; Miller JD; Kimata K; Wight TN
Arch Biochem Biophys; 1995 Jun; 320(1):84-95. PubMed ID: 7793988
[TBL] [Abstract][Full Text] [Related]
16. Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through alpha2beta1 integrin.
Bix G; Fu J; Gonzalez EM; Macro L; Barker A; Campbell S; Zutter MM; Santoro SA; Kim JK; Höök M; Reed CC; Iozzo RV
J Cell Biol; 2004 Jul; 166(1):97-109. PubMed ID: 15240572
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein modulation of subendothelial heparan sulfate proteoglycans (perlecan) and atherogenicity.
Pillarisetti S
Trends Cardiovasc Med; 2000 Feb; 10(2):60-5. PubMed ID: 11150731
[TBL] [Abstract][Full Text] [Related]
18. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
[TBL] [Abstract][Full Text] [Related]
19. Endothelial cells interact with the core protein of basement membrane perlecan through beta 1 and beta 3 integrins: an adhesion modulated by glycosaminoglycan.
Hayashi K; Madri JA; Yurchenco PD
J Cell Biol; 1992 Nov; 119(4):945-59. PubMed ID: 1385448
[TBL] [Abstract][Full Text] [Related]
20. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
Vischer P; Feitsma K; Schön P; Völker W
Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
